Related Experiment Video

Updated: Jun 12, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL

Greg Welder1, Issam Zineh, Michael A Pacanowski

  • 1University of Florida, Gainesville, FL, USA.

Journal of Lipid Research
|June 8, 2010
PubMed

Insights

High-dose atorvastatin (80 mg) significantly increases proprotein convertase subtilisin kexin type 9 (PCSK9) levels. This sustained rise in PCSK9 may explain why higher statin doses offer diminishing returns for lowering LDL-cholesterol.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Pharmacology
  • Lipid Metabolism

Background:

  • Proprotein convertase subtilisin kexin type 9 (PCSK9) is a critical regulator of low-density lipoprotein cholesterol (LDL-C) levels.
  • PCSK9 binds to the LDL receptor (LDLR) in the liver, promoting its degradation and increasing serum LDL-C.
  • Moderate statin doses have been shown to increase PCSK9 levels, potentially limiting further LDL-C reduction.

Purpose of the Study:

  • To investigate the time-dependent effects of high-dose atorvastatin (80 mg) on serum PCSK9 levels.
  • To determine if high-dose atorvastatin alters the correlation between PCSK9 and lipid profiles over time.

Main Methods:

  • Human subjects were administered high-dose atorvastatin (80 mg).
  • Serum PCSK9 and lipid levels (total cholesterol, LDL-C, triglycerides) were measured over a 16-week period.
  • Measurements included a 2-week baseline and subsequent 4-week intervals.

Main Results:

  • High-dose atorvastatin (80 mg) induced a rapid 47% increase in serum PCSK9 within 4 weeks.
  • This PCSK9 elevation was sustained throughout the 16-week study duration.
  • Atorvastatin treatment abolished the baseline correlations between PCSK9 levels and total cholesterol, LDL-C, and triglycerides.

Conclusions:

  • High-dose atorvastatin therapy leads to a significant and sustained increase in serum PCSK9.
  • The observed increase in PCSK9 may contribute to the blunted LDL-C lowering efficacy at higher statin doses.
  • Understanding the PCSK9 response to statins is crucial for optimizing lipid-lowering strategies.

More Related Videos

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK908:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...